GW274150 is a potent, selective, and orally active inhibitor of NADPH-dependent human and rat inducible nitric oxide synthase (iNOS), with demonstrated protective effects in models of acute lung injury and inflammation; it significantly reduces carrageenan-induced lung injury, edema formation, and polymorphonuclear neutrophil (PMN) infiltration in rats in a dose-dependent manner; it also shows neuroprotective effects in a 6-hydroxydopamine (6-OHDA) rat model of Parkinson’s disease, although its efficacy follows a bell-shaped profile with reduced effectiveness at higher doses.